The Drug Pricing Conundrum Explained
Counsel Lanhee Chen recently authored “The Drug Pricing Conundrum Explained” for RealClear Health. The article describes the recent significant discussions on drug pricing and the reality that employers, pharmacy benefit managers (PBMs), and health plans are working to ensure a competitive marketplace and hold down costs for consumers. Lanhee states that the US continues to be a center for pharmaceutical innovation and a leading source of new cures that improve human quality of life and longevity. “While some are calling for additional regulatory or legislative action to deal with drug costs, this only threatens innovation while interfering with a marketplace that is already holding down costs and ensuring broad access to the therapies and cures that Americans need,” concludes Lanhee.
To read the RealClear Health article, click here.